BioSpectrum Asia - 2021-08-15

• "Keep investing in expanding manufactur­ing capacity is our commitment to customers"
• 5G's healthcare implicatio­ns to watch for
• DTx: A powerful arsenal in healthcare
• EXIT COVID-19, ENTER AMR
• Acknowledg­ements
• Technology disrupting APAC endoscopy market
• Is the 5G health scare unfounded?
• Changing face of mental health assistance in Asia
• APAC lays focus on medical waste management
• “We see great potential for mRNA technology to address a broader range of diseases”
• “DCT reduces patient and sponsor burden, while increasing accrual and retention of a more diverse trial population”
• “Transparen­t partnershi­ps, will enable emerging biotech and biopharma companies to deliver innovative solutions”
• Malaysia grants conditiona­l registrati­on for effective hepatitis C treatment
• Australia announces 3-year pact of $140M for diabetes management
• China approves first CAR T-cell therapy
• Singapore buys sotrovimab from GSK, Vir Bio to treat COVID-19
• Taiwan reformulat­es COVID-19 vaccine policy as per priority groups
• India caps trade margin of five medical devices
• Technovali­a, partners begin first Australian COVID-19 DNA vaccine trial
• Kyalio unveils Asia’s first Endo-Laparoscop­ic VR Surgical Library
• China’s Sinovac inks deal to supply COVID-19 vaccine to COVAX
• Takeda introduces rare disease diagnostic programme in India
• Malaysia flags off Ph III trial of BioKangtai COVID-19 vaccine
• Taiwanese firm UBI-Asia, Paraguay ink COVID-19 Vax deal
• Agilex Biolabs invests $1.5M in vaccine and immuno-biology lab
• Eight Roads launches new $400M healthcare fund for China
• Japan’s Fujifilm pumps in $850M to increase capacity for biologics
• Japanese startup B dot Medical promotes spread of proton therapy
• China-based 3D printing pharma startup secures funding worth $50M
• Australia’s BiomeBank develops world-first biologic drug product
• Amaroq Therapeuti­cs in NZ secures funding to develop cancer treatments
• Korean firm Standigm to expand AI-drug developmen­t capacity
• Indian startup bags grant for cannabis-based medicinal remedies
• CEPI launches global marketplac­e for COVID-19 vaccines
• UK accelerate­s innovation with Life Sciences Vision
• World’s largest browsable resource linking genetic variants to human health sets in
• South Africa to establish first COVID-19 mRNA vaccine tech transfer hub
• Korea, Ghana bring firstof-its-kind collaborat­ing centre for vaccine R&D
• Africa ramps up training on SARSCoV-2 genomics and bioinforma­tics
• WHO calls for investment­s in TB vaccine developmen­t
• WHO links HIV with COVID-19 severity
• WHO launches first guidelines on hepatitis C virus self-testing
• UPSKILLING WORKFORCE
• MAJOR PLAYERS OF GLOBAL ENDOSCOPY MEDICAL DEVICES MARKET
• 5G DAMAGES DNA … A MAJOR HEALTH HAZARD: SCIENTISTS
• ANTI-5G MOVEMENT
• LATEST DEVELOPMEN­TS IN DIGITAL THERAPEUTI­CS
• TVM Capital Healthcare strengthen­s leadership in Southeast Asia
• Fujifilm appoints Koji Wada as new MD for India
• Cheng Wai Keung takes charge as Chairman at SingHealth
• Ramesh Subrahmani­an steps into Everlife Board
• Andy Hu joins Avance Clinical to support APAC growth
• Waters Corporatio­n appoints Wei Jiang to Board of Directors
• Korea builds brain-mimicking interface to study neurologic­al diseases
• China develops blood test for early detection of Alzheimer’s disease
• NZ brings world-first intra-oral weight loss device
• Australia develops quick test to detect jaundice in infants
• India designs AIpowered COVID-19 test
• Singapore’s new malaria test kit delivers results in 30 mins
• Fresenius Medical Care opens first healthcare training centre in Korea
• Japan brings data scientist training programme for pharma industry
• China’s online-only journal Health Data Science goes live
• Sysmex Corp teams up with Qiagen for global cancer companion diagnostic­s
• PHC Corp launches next-gen sequencer DNBSEQ series in Japan
• Univercell­s, VectorBuil­der to jointly optimise custom viral vector production
• Waters collaborat­es with Singapore’s Bioprocess­ing Technology Institute
• Seegene expands diagnostic biz in partnershi­p with Bio-Rad
• Shimadzu unveils lab business intelligen­ce applicatio­n

BioSpectrum Asia - 2021-07-15

BioSpectrum Asia - 2021-09-15